Correlation Between Inozyme Pharma and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Agios Pharm, you can compare the effects of market volatilities on Inozyme Pharma and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Agios Pharm.
Diversification Opportunities for Inozyme Pharma and Agios Pharm
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inozyme and Agios is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Agios Pharm go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Agios Pharm
Given the investment horizon of 90 days Inozyme Pharma is expected to generate 1.64 times less return on investment than Agios Pharm. In addition to that, Inozyme Pharma is 1.56 times more volatile than Agios Pharm. It trades about 0.02 of its total potential returns per unit of risk. Agios Pharm is currently generating about 0.06 per unit of volatility. If you would invest 3,032 in Agios Pharm on August 27, 2024 and sell it today you would earn a total of 2,536 from holding Agios Pharm or generate 83.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Agios Pharm
Performance |
| Timeline |
| Inozyme Pharma |
| Agios Pharm |
Inozyme Pharma and Agios Pharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Agios Pharm
The main advantage of trading using opposite Inozyme Pharma and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.| Inozyme Pharma vs. Eliem Therapeutics | Inozyme Pharma vs. HCW Biologics | Inozyme Pharma vs. Scpharmaceuticals | Inozyme Pharma vs. Milestone Pharmaceuticals |
| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |